You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serum Soluble IL-2 Receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Initial Investigation of Patients With Suspected Pneumonia

Active, not recruiting
  • Pneumonia, Bacterial
  • PCT
  • +2 more
  • Aabenraa, Denmark
    Hospital of Southern Jutland
Apr 19, 2022

Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19

Unknown status
  • COVID-19
  • Severe Pneumonia
  • Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
  • Zagreb, Croatia
    University Hospital for Infectious Diseases "Dr Fran Mihaljevic"
Nov 10, 2020

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

Not yet recruiting
  • Glioblastoma
  • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
  • Gainesville, Florida
    University of Florida Health
Jul 29, 2022

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

Recruiting
  • Advanced Glioma
  • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Targeted IL-13 Rα2 UCAR-T cell injection
  • Targeted B7-H3 UCAR-T cell injection
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Mar 2, 2023

SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul

Completed
  • SARS CoV 2 Infection
  • +3 more
    • Istanbul, Turkey
      Haseki Training and Research Hospital
    Nov 17, 2022

    Melanoma, Non Small Cell Lung Cancer, Renal Cancer Trial in Clermont-Ferrand (Blood sample)

    Recruiting
    • Melanoma
    • +2 more
    • Blood sample
    • Clermont-Ferrand, France
      CHU de Clermont-Ferrand
    Jun 16, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Bintrafusp Alfa
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 2, 2022

    Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

    Recruiting
    • Neuroblastoma
    • Osteosarcoma
    • iC9.GD2.CAR.IL-15 T-cells
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Jan 4, 2023

    Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • iC9.GD2.CAR.IL-15 T Infusion
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Nov 16, 2022

    Recurrent Malignant Glioma Trial in Goyang-si (YYB-103)

    Recruiting
    • Recurrent Malignant Glioma
    • Goyang-si, Gyeonggi, Korea, Republic of
      National Cancer Center, Korea
    Sep 12, 2022

    sCLEC-2 in Stroke Study

    Not yet recruiting
    • Acute Ischemic Stroke
    • Transient Ischemic Attack
      • Katori, Chiba, Japan
      • +8 more
      Oct 10, 2022

      Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

      Recruiting
      • Recurrent Diffuse Large B-Cell Lymphoma
      • +8 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Dec 30, 2022

      Diabetes Type 2 in Obese, Inflammation, Metabolic Disease Trial in Basel (Anakinra Prefilled Syringe)

      Recruiting
      • Diabetes Mellitus Type 2 in Obese
      • +3 more
      • Anakinra Prefilled Syringe
      • Basel, Basel BS, Switzerland
        University Hospital Basel
      Sep 7, 2021

      Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

      Recruiting
      • Corona Virus Infection
      • ELISA
      • Assiut, Egypt
        AssiutU
      Feb 2, 2023

      Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

      Recruiting
      • Primary Immune Thrombocytopenia
      • Plasma RNA isolation, qPCR analysis of micro RNA
      • +2 more
      • Sohag, Egypt
        Sohag University
      May 7, 2022

      Serum Soluble ST2 and Plaque Vulnerability in Acute Coronary

      Completed
      • Acute Coronary Syndrome
      • Coronary plaque components
      • Shanghai, China
        Cardiology, Ren Ji Hospital
      Mar 20, 2021

      Kita-kyushu Lung Cancer Antigen 1, Human Trial run by the NCI (IL-2 (Aldesleukin), Cyclophosphamide, KK-LC-1 TCR)

      Recruiting
      • Kita-kyushu Lung Cancer Antigen 1, Human
      • IL-2 (Aldesleukin)
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 27, 2022

      Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

      Recruiting
      • Subarachnoid Hemorrhage
      • Plymouth, Devon, United Kingdom
      • +11 more
      May 16, 2022

      Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy

      Not yet recruiting
      • Diabetic Nephropathy Type 2
      • Enzyme linked immunosorbent assay
      • (no location specified)
      Jul 4, 2021

      Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

      Recruiting
      • Non-Hodgkin Lymphoma
      • Relapsed/Refractory Diffuse Large B-cell Lymphoma
      • NKTR-255 at 1.5 µg/kg
      • +3 more
      • La Jolla, California
      • +26 more
      Jan 10, 2023

      Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic

      Completed
      • Obesity
      • +2 more
        • New Orleans, Louisiana
          Tulane Medical Center
        Feb 24, 2021

        Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

        Recruiting
        • Ependymoma
        • +3 more
        • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
        • Duarte, California
          City of Hope Medical Center
        Mar 9, 2022